Valuation: Crossject

Market Cap 98M 112M 90.06M 83.95M 159M 10.67B 162M 1.08B 420M 5.25B 421M 412M 18.08B P/E 2026 *
4.39x
P/E 2027 * 3.46x
Enterprise Value 80.1M 91.63M 73.61M 68.61M 130M 8.72B 132M 884M 344M 4.29B 344M 337M 14.78B EV / Sales 2026 *
1.32x
EV / Sales 2027 * 1.21x
Free-Float
90.34%
Yield 2026 *
-
Yield 2027 * -
1 day+0.67%
1 week-1.75%
Current month+0.90%
1 month-9.64%
3 months-11.98%
6 months-16.08%
Current year-17.81%
1 week 1.76
Extreme 1.764
1.87
1 month 1.76
Extreme 1.764
2.03
Current year 1.76
Extreme 1.764
2.58
1 year 1.35
Extreme 1.346
2.7
3 years 0.72
Extreme 0.7199
5.96
5 years 0.72
Extreme 0.7199
5.96
10 years 0.72
Extreme 0.7199
8.36
Manager TitleAgeSince
Chief Executive Officer 63 08/08/2001
Director of Finance/CFO - 25/03/2026
Corporate Officer/Principal - 20/08/2024
Director TitleAgeSince
Chairman 67 26/06/2009
Director/Board Member 67 -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
04/07/25Buy

Director

13,386 0.0266%
01/07/25Buy

Director

50 0.0001%
01/07/25Buy

Director

2,878 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
+0.67%-1.75%+6.01%-53.61% 112M
+0.35%+4.82%-26.52%-69.60% 89.61M
-0.98%-3.01%+65.89%+4.41% 68.01M
Average +0.01%+0.02%+15.12%-39.60% 89.91M
Weighted average by Cap. +0.15%+0.11%+10.30%-44.29%

Financials

2026 *2027 *
Net sales 60.8M 69.55M 55.88M 52.08M 98.79M 6.62B 100M 671M 261M 3.26B 261M 255M 11.22B 42.3M 48.39M 38.87M 36.23M 68.73M 4.61B 69.77M 467M 181M 2.26B 182M 178M 7.8B
Net income 28.3M 32.37M 26.01M 24.24M 45.98M 3.08B 46.68M 312M 121M 1.52B 122M 119M 5.22B 7.75M 8.87M 7.12M 6.64M 12.59M 844M 12.78M 85.5M 33.24M 415M 33.28M 32.56M 1.43B
Net Debt -17.9M -20.48M -16.45M -15.33M -29.08M -1.95B -29.52M -197M -76.77M -958M -76.86M -75.21M -3.3B -47M -53.76M -43.19M -40.26M -76.36M -5.12B -77.52M -519M -202M -2.52B -202M -197M -8.67B
Logo Crossject
Crossject specializes in manufacturing and marketing needleless drug self-injection. The group provides Zeneo, a prefilled and single-use device that can be used for intradermal, subcutaneous and intramuscular injections.
Employees
99
Date Price Change Volume
03/07/26 €1.800 +0.67% 108,931
02/07/26 €1.788 -0.45% 88,832
01/07/26 €1.796 +0.67% 203,636
30/06/26 €1.784 -3.25% 272,088
29/06/26 €1.844 +0.66% 98,488
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.800EUR
Average target price
4.400EUR
Spread / Average Target
+144.44%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALCJ Stock